Clinical Trial Update: Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia [Phase 4]

View source ↗

Summary

Phase 4 pharmacodynamic study evaluating ceftaroline fosamil and levofloxacin against pathogens associated with community-acquired pneumonia; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Levaquin (levofloxacin)
• Teflaro (ceftaroline fosamil)

Snippet

Sponsor: Gary E. Stein, Pharm.D. | Conditions: Pneumonia, Bacterial, Community-acquired | Phase 4 | Status: COMPLETED | Results posted: 2016-04-12